The abstract is read at the publisher; the summary is JClub's.
Adding Contrave to breast cancer survivors who had <5% weight loss after 2 months of behavioral weight loss produced ≥5% weight loss in 42% by 6 months.
- Why it matters: Remote coaching and self-monitoring weight loss has limited effectiveness in breast cancer survivors, leaving a need for strategies that help those who respond poorly early.
- What they did: In a single-arm phase II A-NEW study, women with prior stage 0 to III breast cancer and BMI ≥27 kg/m2 started BWL, then at 2 months split into FAST-BWL (≥5% WL) or SLOW-BWL (<5% WL) to receive BWL plus Contrave.
- The result: From 2 to 6 months, mean %WL was similar between groups, but at 6 months SLOW-BWL had 5.1% (2.9) mean %WL and 16/38 (42%) reached ≥5% WL; HbA1c and triglycerides improved, while gastrointestinal symptoms occurred in 74% of SLOW-BWL.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.